Key result
Female patients on statin therapy had a significantly lower LDL-C goal attainment rate compared to male patients (46.0% vs 53.8%), with baseline LDL-C levels being the primary contributor.
Why the study?
What factors explain the gender disparity in LDL-C goal attainment rates among Chinese patients on statin therapy?
Observational (n=1,808)
Yes
What factors explain the gender disparity in LDL-C goal attainment rates among Chinese patients on statin therapy?
Absolute Event Rate: 46% vs 53.8%
p-value: p=0.002
Women in China have significantly lower LDL-C goal attainment rates on statin therapy compared to men, with only half of this disparity explained by baseline clinical, socioeconomic, and treatment factors.
May warrant closer LDL-C monitoring in Chinese women on statins; leaves open unmeasured factors explaining residual gender disparity.
BACKGROUND: The lipid-lowering treatment goal attainment rate is lower for women than for men among Chinese patients, but the reasons for this disparity have not been fully explored yet. OBJECTIVES: To elucidate the potential factors and the significance of their contributions towards the observed discrepancy in lipid-lowering treatment goal attainment rates between Chinese women and men. METHODS: We used data from 1808 patients from 21 tertiary and 6 secondary hospitals in China who received and maintained statin therapy treatment for at least 2 months. Lipid-lowering treatment goal attainment was defined as low-density lipoprotein cholesterol (LDL- C) reaching the treatment targets recommended by the Chinese Guidelines on Prevention and Control of Dyslipidemia in Adults. Logistic Regression was used to explore possible factors associated with gender disparity in goal attainment rates, and to what extent each factor contributes. RESULTS: A total of 674 women and 1134 men were enrolled in the study. Women had a significantly lower LDL-C goal attainment rate than that of men (46.0% vs 53.8%, P = 0.002), particularly in high and very high CVD risk groups. Among high and very high risk patients, approximately 35%, 7%, 5%, and 5% of gender disparity in LDL-C goal attainment rate was attributable to the gender difference in baseline LDL-C level, cardiovascular co-morbidities and associated risk factors, socioeconomic status, and the dosage of statin treatment, respectively. Approximately 50% of the gender disparity remained unexplained by these factors. CONCLUSIONS: Although nearly half of the gender disparity in lipid-lowering treatment goal attainment rate can be explained by the gender differences in baseline lipid level, socioeconomic status, cardiovascular co-morbidities and associated risk factors, and the dosage of statin in high and very high CVD risk patients, the other half of the gender disparity remains unexplained and requires further study to fully understand what other factors are at play.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2012) conducted an observational in Dyslipidemia (n=1,808). Female gender vs. Male gender was evaluated on LDL-C treatment goal attainment (p=0.002). Female patients on statin therapy had a significantly lower LDL-C goal attainment rate compared to male patients (46.0% vs 53.8%), with baseline LDL-C levels being the primary contributor.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: